Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Takeda Pharmaceutical Company, a Japan-based pharmaceutical company, has appointed Erich Brunn as CEO of Takeda Pharmaceuticals Europe, its wholly owned subsidiary for oversight of pan-European sales and marketing.
Subscribe to our email newsletter
Dr Brunn has a doctorate in chemistry and, since 2001, has been president of Takeda Pharma, a wholly owned subsidiary of Takeda in Germany. He previously worked at Upjohn, Pharmacia & Upjohn and Pharmacia in various functions.
Yasuchika Hasegawa, president of Takeda, said: “Dr Brunn has a proven track record of success and excellence, which is apparent through the remarkable growth achieved by Takeda Pharma under his leadership. We are confident that he will provide Takeda Pharmaceuticals Europe (TPEU) with the same level of success as he takes on this pivotal role as CEO of TPEU.”